Abstract:Objectives The purpose of this study was to demonstrate real status of clinical management for patients with ACS (acute coronary syndromes) in China. Background The extent of use of established practice guidelines for ACS that have been implemented in contemporary clinical practice in China is unknown. Methods This study is a retrospective observational survey, 64 hospitals across China, involving 3,139 in-patients with ACS were included and standard questionnaires were used to get baseline information on patients' demographic, treatment practice and in-hospital and postdischarge outcomes. Data were analyzed to present the full spectrum of ACS in specific geographic populations. Results 1. The proportion of patients involved presented the spectrum as follows: ST elevation MI (myocardial infarction) 39.2% (1,304), non-ST MI 10.5% (348) and unstable angina 44.8% (1,487), no significant difference was observed between tertiary hospitals and secondary hospitals. 2. In ST elevation MI, reperfusion was applied more often in tertiary hospitals (57.9%) than in secondary hospitals (42.3%). However, the rate of lytic treatment was higher in secondary hospitals than that in tertiary hospitals (37.4% vs 14.5%). 3. Statins and glycoprotein IIb/IIIa antagonists were applied more frequently in tertiary hospitals for all classes of patients with ACS (p<0.001). 4. Major in-hospital events and death rates were higher in secondary hospitals than tertiary hospitals. Conclusions In contrast with European and some western countries, current management of ACS in China showed that it less closely follows the recommendations of guidelines. Differences in practice can be observed between different level hospitals. Objectives The purpose of this study was to demonstrate real status of clinical management for patients with ACS (acute coronary syndromes) in China. Background The extent of use of established practice guidelines for ACS that have been implemented in contemporary clinical practice in China is unknown. Methods This study is a retrospective observational survey, 64 hospitals across China, involving 3,139 in-patients with ACS were included and standard questionnaires were used to get baseline information on patients' demographic, treatment practice and in-hospital and postdischarge outcomes. Data were analyzed to present the full spectrum of ACS in specific geographic populations. Results 1. The proportion of patients involved presented the spectrum as follows: ST elevation MI (myocardial infarction) 39.2% (1,304), non-ST MI 10.5% (348) and unstable angina 44.8% (1,487), no significant difference was observed between tertiary hospitals and secondary hospitals. 2. In ST elevation MI, reperfusion was applied more often in tertiary hospitals (57.9%) than in secondary hospitals (42.3%). However, the rate of lytic treatment was higher in secondary hospitals than that in tertiary hospitals (37.4% vs 14.5%). 3. Statins and glycoprotein IIb/IIIa antagonists were applied more frequently in tertiary hospitals for all classes of patients with ACS (p<0.001). 4. Major in-hospital events and death rates were higher in secondary hospitals than tertiary hospitals. Conclusions In contrast with European and some western countries, current management of ACS in China showed that it less closely follows the recommendations of guidelines. Differences in practice can be observed between different level hospitals.

Invasive Management Strategies And Antithrombotic Treatments In Patients With Non-St-Segment-Elevation Acute Coronary Syndrome In China Findings From The Improving Ccc Project (Care For Cardiovascular Disease In China)

Clinical Analysis of 373 Patients with Non-ST Elevation Acute Coronary Syndrome in a Teaching Hospital

INVASIVE MANAGEMENT STRATEGIES AND ANTI-THROMBOTIC TREATMENTS IN PATIENTS WITH NSTE-ACS IN CHINA

Performance on Management Strategies with Class I Recommendation and A Level of Evidence among Hospitalized Patients with Non-St-segment Elevation Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project

Contemporary Invasive Management and In-Hospital Outcomes of Patients with Non–st-Segment Elevation Myocardial Infarction in China: Findings from China Acute Myocardial Infarction (CAMI) Registry

Anticoagulant Therapy for Non-St-Segment Elevation Acute Coronary Syndrome in China: A Multi-Center Observational Study

Percutaneous Coronary Intervention Among Patients With non-ST-segment Elevation Myocardial Infarction and Unstable Angina: Findings From the Improving Care for Cardiovascular Disease in China Project

Treatment delay and reperfusion management of acute ST-segment elevation myocardial infarction: analysis of the China STEMI Care Project Phase 1

Regional Variations in Management and Outcomes of Patients with Acute Coronary Syndrome in China: Evidence from the National Chest Pain Center Program

Abstract 10950: Real-World Practice of Reperfusion and Revascularization in Patients with St-Segment Elevation Myocardial Infarction in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project

E0258 Current Clinical Practice and Guideline Application in Therapies of ST Segment Elevation ACS Inpatient in a Multi-Provincial Study in China: Results of BRIG Project

Trends in Percutaneous Coronary Intervention in China: Analysis of China PCI Registry Data from 2010 to 2018

Clinical characteristics and in-hospital management strategies in patients with acute coronary syndrome: results from 2,096 accredited Chest Pain Centers in China from 2016 to 2021

Efficacy and Safety of Serial Atorvastatin Load in Chinese Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ISCAP (intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) Randomized Controlled Trial

A Cross-Sectional Study On Health Care For Acute Coronary Syndromes In China

Timing of angiography and outcomes in patients with non-ST-segment elevation myocardial infarction: Insights from the evaluation and management of patients with acute chest pain in China registry

Early Invasive Strategy For Non-St Elevation Acute Coronary Syndrome: A Meta-Analysis Of Randomized, Controlled Trials

Quality of Care for Patients with Non-ST-Segment Elevation Acute Coronary Syndrome in China: Findings from Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project

The Studies of Risk Factors and Early Intervention in Patients with Acute Coronary Syndromes Without ST-segment Elevation

Long-term Follow-Up of Antithrombotic Management Patterns in Patients with Acute Coronary Syndrome in China

Rationale and Design of the Improving Care for Cardiovascular Disease in China (CCC) Project: A National Effort to Prompt Quality Enhancement for Acute Coronary Syndrome.